Magnetic bacteria possess extraordinary capabilities due to the magnetic nanoparticles, the magnetosomes, which are concatenated inside their cells. A research team at the University of Bayreuth has now transferred all of the approximately 30 genes responsible for the production of these particles to non-magnetic bacteria in a broad series of experiments.
Based on extensive studies, the researchers initially identified 25 species of non-magnetic proteobacteria—by far the most extensive domain of bacteria—that are particularly suitable for gene transfer and for studying magnetosome formation. Both biochemical properties and the availability of specific gene sequences were decisive factors.
Magnetization was successful in seven species: these bacteria continuously produce magnetosomes in which iron-containing magnetite crystals are chained together in a manner similar to that in the donor bacterium Magnetospirillum gryphiswaldense.
“In terms of future applications in biomedicine, it is particularly promising that two species of bacteria that we have successfully genetically engineered are already widely used in biotechnology.”
“According to the current state of research, they are well compatible with human cells. This opens up new perspectives for a variety of biomedical applications—for example, for microrobot-controlled transport of active pharmaceutical ingredients, for magnetic imaging techniques, or even for optimizations of hyperthermia cancer therapy,” says the first author of the new study, Dr. Marina Dziuba, who is a research associate at the Microbiology research group in Bayreuth.
The Bayreuth researchers have studied the magnetosomes produced by the new transgenic bacterial strains in more detail and thus identified a number of factors that could be causally involved in magnetosome formation.
Comparison between the genome of these strains and the genome of those genetically modified bacteria that failed to produce magnetosomes has also led to valuable insights. There is much evidence to suggest that the magnetosome formation of transgenic bacterial strains is closely related to their ability to photosynthesize or to engage in oxygen-independent, so-called anaerobic respiration processes.
Overall, the new study shows that it is not single or a few particular genes that transgenic bacteria lack when they are incapable of magnetosome formation. Rather, the decisive factor for them to synthesize magnetosomes after receiving the foreign gene clusters is a combination of certain metabolic properties and the ability to efficiently use the genetic information of the foreign genes to produce cellular proteins.
“Our study shows that further research is needed to understand the biosynthesis of magnetosomes in detail, identify barriers to their transfer, and develop strategies to overcome them. At the same time, however, our results shed new light on metabolic processes that support magnetosome formation. They therefore provide a framework for future investigations on the way to designing new strains of biocompatible magnetic bacteria tailored for biomedical and biotechnological innovations,” explains Prof. Dr. Dirk Schüler, Chair of Microbiology at the University of Bayreuth.
In earlier research, the Bayreuth team had already succeeded in introducing the genes responsible for magnetosome formation from the bacterium Magnetospirillum gryphiswaldense—a model organism for research—into the genome of non-magnetic bacteria. However, in only a few cases, this gene transfer resulted in genetically modified bacteria that, in turn, began to form magnetosomes.
It remained completely unclear which factors might influence whether transgenic bacteria produced magnetosomes. Against this background, the study now published, in which a research partner at the University of Pannonia in Veszprém/Hungary also participated, provides important new impetus for the targeted magnetization of living cells.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
